CHIEF MEDICAL OFFICER
CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc., filing insider transactions between 2026-02-17 and 2026-06-17.
| SEC ↗ |
| 2026-05-18 | ELVN | Sale | 223 | $41.21 | $9K | SEC ↗ |
| 2026-05-18 | ELVN | Sale | 1,302 | $40.25 | $52K | SEC ↗ |
| 2026-05-18 | ELVN | Sale | 3,475 | $39.53 | $137K | SEC ↗ |
| 2026-04-17 | ELVN | Sale | 2,441 | $48.06 | $117K | SEC ↗ |
| 2026-04-17 | ELVN | Sale | 140 | $45.81 | $6K | SEC ↗ |
| 2026-04-17 | ELVN | Sale | 2,419 | $47.39 | $115K | SEC ↗ |
| 2026-03-25 | ELVN | Sale | 40.0K | $35.10 | $1.4M | SEC ↗ |
| 2026-03-17 | ELVN | Sale | 5,000 | $27.76 | $139K | SEC ↗ |
| 2026-03-10 | ELVN | Sale | 10.1K | $30.19 | $306K | SEC ↗ |
| 2026-03-09 | ELVN | Sale | 29.9K | $30.02 | $897K | SEC ↗ |
| 2026-02-17 | ELVN | Sale | 45.0K | $26.17 | $1.2M | SEC ↗ |